Launay-Vacher V - Search Results

1

Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice.

Aloy B, Launay-Vacher V, Bleibtreu A, Bortolotti P, Faure E, Filali A, Gauzit R, Gilbert M, Lesprit P, Mahieu R, Meyssonnier V, Ogielska M, Romaru J, Salmon D, Alfandari S, Lemaignen A. Aloy B, et al. Among authors: launay vacher v. Med Mal Infect. 2020 Jun;50(4):323-331. doi: 10.1016/j.medmal.2019.06.010. Epub 2019 Jul 17. Med Mal Infect. 2020. PMID: 31326299 Review.

2

[Reply to the article Non-VKA oral anticoagulants: an update for the clinical biologists].

Janus N, Aloy B, Deray G, Launay-Vacher V. Janus N, et al. Ann Biol Clin (Paris). 2015 Nov-Dec;73(6):741-3. doi: 10.1684/abc.2015.1098. Ann Biol Clin (Paris). 2015. PMID: 26635055 Free article. French. No abstract available.

3

[Renovascular effects of antiangiogenic drugs].

Deray G, Janus N, Aloy B, Launay-Vacher V. Deray G, et al. Bull Cancer. 2016 Jul-Aug;103(7-8):662-6. doi: 10.1016/j.bulcan.2016.05.005. Epub 2016 Jun 16. Bull Cancer. 2016. PMID: 27318610 Review. French.

4

Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?

Aloy B, Tazi I, Bagnis CI, Gauthier M, Janus N, Launay-Vacher V, Deray G, Tourret J. Aloy B, et al. AIDS Rev. 2016 Oct-Dec;18(4):184-192. AIDS Rev. 2016. PMID: 27438578 Free article. Review.

5

[Renal toxicity of anticancer drugs].

Aloy B, Janus N, Isnard-Bagnis C, Deray G, Launay-Vacher V. Aloy B, et al. Among authors: launay vacher v. Nephrol Ther. 2021 Dec;17(7):553-563. doi: 10.1016/j.nephro.2021.09.001. Epub 2021 Nov 18. Nephrol Ther. 2021. PMID: 34802974 French.

6

[Pharmacokinetics of amprenavir in HIV-1 patients with renal insufficiency].

Janus N, Launay-Vacher V, Izzedine H, Karie S, Laville I, Deray G. Janus N, et al. Med Mal Infect. 2007 Dec;37(12):832-4. doi: 10.1016/j.medmal.2006.11.017. Epub 2007 Nov 7. Med Mal Infect. 2007. PMID: 17997253 French.

7

Anticancer Drugs in End-Stage Kidney Disease Patients.

Janus N, Launay-Vacher V. Janus N, et al. Semin Dial. 2015 Jul-Aug;28(4):413-6. doi: 10.1111/sdi.12371. Epub 2015 Apr 11. Semin Dial. 2015. PMID: 25864698

8

[How to adjust the dose of drugs in chronic kidney disease?].

Launay-Vacher V, Janus N, Zimner-Rapuch S, Amet S, Deray G. Launay-Vacher V, et al. Rev Prat. 2012 Mar;62(3):309-11, 314-5. Rev Prat. 2012. PMID: 22514978 French.

9

[Drug dosage adjustment in patients with renal impairment and evaluation of renal function: focus on the cardiologic patients].

Zimner-Rapuch S, Amet S, Janus N, Deray G, Launay-Vacher V. Zimner-Rapuch S, et al. Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):1-8. doi: 10.1016/j.ancard.2014.04.006. Epub 2014 Apr 29. Ann Cardiol Angeiol (Paris). 2015. PMID: 24856657 French.

10

[Clarification of the method used for drug dosage adjustment in patients with renal failure: The CLEAR study].

Berdougo J, Delorière É, Deray G, Launay-Vacher V. Berdougo J, et al. Among authors: launay vacher v. Nephrol Ther. 2020 Feb;16(1):59-64. doi: 10.1016/j.nephro.2019.09.003. Epub 2020 Jan 24. Nephrol Ther. 2020. PMID: 31987727 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page